Drug profile · INN
methysergide maleate
SANSERT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
methysergide maleate (SANSERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN methysergide maleate
Brand SANSERT
Route ORAL
Formulation TABLET
Frequently asked questions
What is methysergide maleate?
methysergide maleate (SANSERT) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for methysergide maleate?
SANSERT is a marketed brand name for methysergide maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methysergide maleate?
methysergide maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.